Global infectious diseases in-vitro diagnostics market size to expand at 3.8% CAGR through 2027

NEXT STORY
Sharps Compliance Reports Fiscal 2021 Third Quarter Results
PREV STORY
Clinical Trial Supply & Logistics for Pharmaceutical Market Research Report by Phase, by Sector, by Therapeutic Area – Global Forecast to 2025 – Cumulative Impact of COVID-19
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cellectar Biosciences to Present at the 5th Annual SeeThru Equity Microcap Investor Conference

MADISON, Wis., May 24, 2016 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused ...

author_avatar
NASDAQ Market News

Argos Therapeutics Announces Pricing of $50 Million Public Offering of Common Stock and Warrants

DURHAM, N.C., July 28, 2016 (GLOBE NEWSWIRE) -- Argos Therapeutics, Inc. (Nasdaq:ARGS) (“Argos”), an ...

author_avatar
NASDAQ Market News

TESARO Announces Fourth-Quarter and Full-Year 2017 Operating Results

ZEJULA is the #1 PARP inhibitor for women with ovarian cancer in the U.S.2017 ...

author_avatar
NASDAQ Market News